10/26/19

AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, October 26-30, 2019

Poster Presentation: Discovery of KYM-003, a potent and selective STAT3 degrader with anti-tumor activity in heme malignancies